EPINEPHRINE DELIVERY DEVICE
State of IllinoisIllinoisAmends various Acts to change references from "epinephrine auto-injector" or "epinephrine injector" to "FDA approved epinephrine delivery device or product". Changes the name of the Epinephrine Injector Act to the FDA Approved Epinephrine Delivery Device or Product Act.
- Status
- Passed
- Signed or otherwise enacted
- Status date
- Aug 7, 2026
- 97 days ago
- Current chamber
- House of Representatives
- Session
- 2025-2026 Regular Session
IL HB 3454 · PassedAug 7
Follow the legislation that affects what you sell.
Get started freeFree account · 30-second setup · No credit card
What it means for vendors
Civic IQ reads each bill for what it would fund, require or change for the agencies that buy.
Bill details
- Last action
- Public Act . . . . . . . . . 104-0762 · Aug 7, 2026
Sponsors
JMJoyce MasonRepresentative · Democrat · HD-061Primary sponsorPrimary sponsor
SGSuzanne Glowiak HiltonSenator · Democrat · SD-023Primary sponsorPrimary sponsor
MDMartha DeuterRepresentative · Democrat · HD-045
NMNatalie ManleyRepresentative · Democrat · HD-098
JYJanet Yang RohrRepresentative · Democrat · HD-041
JWJawaharial WilliamsRepresentative · Democrat · HD-010
HBHarry BentonRepresentative · Democrat · HD-097
DADagmara AvelarRepresentative · Democrat · HD-085
Show 3 more sponsors
CLCamille LillyRepresentative · Democrat · HD-078
MMMichelle MussmanRepresentative · Democrat · HD-056
MEMary Edly-AllenSenator · Democrat · SD-031
Bill history
Newest first.
Aug 7, 2026Public Act . . . . . . . . . 104-0762House
Aug 7, 2026Effective Date January 1, 2027House
Aug 7, 2026Governor ApprovedHouse
Jun 26, 2026Sent to the GovernorHouse
May 31, 2026Passed Both HousesHouse
May 31, 2026House ConcursHouse
May 31, 2026Senate Floor Amendment No. 2 House Concurs 116-000-000House
May 29, 2026Senate Floor Amendment No. 2 Motion to Concur Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee; 013-000-000House
Show 48 earlier actions
May 29, 2026Senate Floor Amendment No. 2 Motion to Concur Rules Referred to Prescription Drug Affordability & Accessibility CommitteeHouse
May 29, 2026Added Chief Co-Sponsor Rep. Natalie A. ManleyHouse
May 29, 2026Senate Floor Amendment No. 2 Motion to Concur Referred to Rules CommitteeHouse
May 29, 2026Senate Floor Amendment No. 2 Motion Filed Concur Rep. Joyce MasonHouse
May 28, 2026Placed on Calendar Order of Concurrence Senate Amendment(s) 2House
May 28, 2026Arrived in HouseHouse
May 28, 2026Added as Alternate Co-Sponsor Sen. Mary Edly-AllenSenate
May 28, 2026Senate Committee Amendment No. 1 Tabled Pursuant to Rule 5-4(a)Senate
May 28, 2026Third Reading - Passed; 059-000-000Senate
May 28, 2026Placed on Calendar Order of 3rd ReadingSenate
May 28, 2026Senate Floor Amendment No. 2 Adopted; Glowiak-HiltonSenate
May 28, 2026Recalled to Second ReadingSenate
May 22, 2026Rule 2-10 Third Reading Deadline Established As May 31, 2026Senate
May 19, 2026Senate Floor Amendment No. 2 Be Approved for Consideration AssignmentsSenate
May 18, 2026Senate Floor Amendment No. 2 Referred to AssignmentsSenate
May 18, 2026Senate Floor Amendment No. 2 Filed with Secretary by Sen. Suzy Glowiak HiltonSenate
May 14, 2026Placed on Calendar Order of 3rd Reading May 18, 2026Senate
May 14, 2026Second ReadingSenate
May 6, 2026Placed on Calendar Order of 2nd Reading May 7, 2026Senate
May 6, 2026Do Pass Insurance; 009-000-000Senate
May 6, 2026Senate Committee Amendment No. 1 Referred to AssignmentsSenate
May 6, 2026Senate Committee Amendment No. 1 Filed with Secretary by Sen. Suzy Glowiak HiltonSenate
Apr 28, 2026Assigned to InsuranceSenate
Mar 26, 2026Referred to AssignmentsSenate
Mar 26, 2026First ReadingSenate
Mar 26, 2026Chief Senate Sponsor Sen. Suzy Glowiak HiltonSenate
Mar 9, 2026Added Chief Co-Sponsor Rep. Janet Yang RohrHouse
Mar 2, 2026Added Co-Sponsor Rep. Michelle MussmanHouse
Feb 26, 2026Placed on Calendar Order of First Reading March 3, 2026Senate
Feb 26, 2026Arrive in SenateSenate
Feb 25, 2026Third Reading - Short Debate - Passed 105-000-000House
Feb 25, 2026Placed on Calendar Order of 3rd Reading - Short DebateHouse
Feb 13, 2026Placed on Calendar 2nd Reading - Short DebateHouse
Feb 11, 2026Approved for Consideration Rules Committee; 005-000-000House
Jan 21, 2026Added Chief Co-Sponsor Rep. Martha DeuterHouse
Apr 11, 2025Rule 19(a) / Re-referred to Rules CommitteeHouse
Apr 8, 2025Added Co-Sponsor Rep. Camille Y. LillyHouse
Mar 26, 2025Held on Calendar Order of Second Reading - Short DebateHouse
Mar 26, 2025Second Reading - Short DebateHouse
Mar 26, 2025Added Co-Sponsor Rep. Dagmara AvelarHouse
Mar 26, 2025Added Co-Sponsor Rep. Harry BentonHouse
Mar 26, 2025Added Co-Sponsor Rep. Jawaharial WilliamsHouse
Mar 20, 2025Placed on Calendar 2nd Reading - Short DebateHouse
Mar 19, 2025Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000House
Mar 11, 2025Assigned to Prescription Drug Affordability & Accessibility CommitteeHouse
Feb 18, 2025Referred to Rules CommitteeHouse
Feb 18, 2025First ReadingHouse
Feb 7, 2025Filed with the Clerk by Rep. Joyce MasonHouse
Recorded votes
House Prescription Drug Affordability CommitteeMar 19, 2025 · House · 6 yea · 0 nayPassedPassed
Senate Insurance CommitteeMay 5, 2026 · Senate · 9 yea · 0 nayPassedPassed
House Prescription Drug Affordability CommitteeMay 29, 2026 · House · 13 yea · 0 nayPassedPassed
House Third ReadingFeb 25, 2026 · House · 105 yea · 0 nayPassedPassed
Senate Third ReadingMay 28, 2026 · Senate · 59 yea · 0 nayPassedPassed
House ConcurrenceMay 31, 2026 · House · 116 yea · 0 nayPassedPassed
Read the bill at the source
This page follows the bill as the legislature records it. For the bill's full text and the official record, use the legislature's own site.
Bill data from LegiScan, licensed under CC BY 4.0.